2012-02-14 15:14:11 -

BERKELEY, CA -- (Marketwire) -- 02/14/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Dino Dina, M.D., Chief Executive Officer, will be presenting at the Citigroup 2012 Global Health Care Conference to be held February 27-29, and at the Cowen and Company 32nd Annual Health Care Conference being held March 5-7, 2012.





Event: Citigroup 2012 Global Health Care Conference
Date: Tuesday, February 28, 2012
Time: 8:30 AM (ET)
Place: Waldorf Astoria, New York, NY



Event: Cowen and Company 32nd Annual Health Care Conference
Date: Tuesday, March 6, 2012
Time: 10:00 AM (ET)
Place: The Boston Marriott Copley Place, Boston, MA



To access the live webcast and the subsequent archived recording of the presentations, please log onto Dynavax's website at investors.dynavax.com/newsevents.cfm : investors.dynavax.com/newsevents.cfm .



About Dynavax



Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com : www.dynavax.com/ .




Contact:
Jennifer Lew
Vice President, Finance
510-665-7217
Email Contact : www2.marketwire.com/mw/emailprcntct?id=794EDF8AFF609A17